IGF1 and proximal spinal muscular atrophy: It is possible that effects on SMA neuromuscular function could be mediated through peripheral organ secretion of neurotrophic factors such as IGF-1, which, together with its binding protein IGFALS has reduced expression in patients and mouse models of SMA (64, 69).